Johnson & Johnson JNJ Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $21.04B-3.5% | $26.8B+90.6% | $25.12B+71.1% | $22.66B-40.4% | $21.81B-43.3% | ||
| $7.74B+6.0% | $7.5B+2.2% | $7.39B+1.4% | $7.46B+2.6% | $7.3B-1.7% | ||
| $1.37B+17.6% | $1.35B+15.1% | $1.28B+15.0% | $1.23B+10.2% | $1.16B+0.3% | ||
| —— | —— | $5.2B+211% | $2.98B— | $1.46B— | ||
| —— | —— | —— | —— | —— | ||
| $1.74B+87.4% | $1.45B+28.5% | $1.49B+43.9% | $1.05B-27.7% | $926M-27.1% | ||
| $583M— | $2.38B— | —— | —— | —— | ||
| —— | —— | —— | —— | -$6.05B— | ||
| $22.87B-7.7% | $24.53B+1.1% | $24.2B-3.7% | $23.03B-6.5% | $24.78B+6.9% | ||
| $5.09B+15.3% | $4.83B+9.2% | $4.61B+4.7% | $4.48B+3.2% | $4.41B-1.7% | ||
| —— | $17.5B+15.5% | $14.46B-4.5% | $14.8B-0.1% | $13.34B+636% | ||
| $813M-39.6% | $920M-46.7% | $939M-60.7% | $973M-59.5% | $1.35B-82.6% | ||
| -$24.33B-32.0% | -$23.59B-26.8% | -$20.42B— | -$23.01B— | -$18.43B— | ||
| $7.85B+155% | $5.95B+145% | $4.31B+82.2% | $2.95B+7.3% | $3.08B+3.1% | ||
| —— | —— | —— | —— | $15.8B+306% | ||
| -$15.43B-329% | -$5.54B-76.9% | -$5.51B+14.5% | -$6.47B+18.0% | $6.74B+131% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | -$1.75B— | -$6.3B— | —— | ||
| —— | $1.86B-2.5% | $1.88B0.0% | $1.89B+2.6% | $1.9B+5.4% | ||
| —— | $6.54B-2.6% | $6.58B-8.3% | $6.63B-13.3% | $6.67B-17.7% | ||
| $210M-16.0% | $204M-49.6% | $149M-82.6% | $56M-95.6% | $250M-77.1% | ||
| $177M-41.2% | $264M+16.8% | $133M-40.9% | $78M-73.4% | $301M+176% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | $6.89B— | —— | —— | ||
| —— | —— | $16M+245% | $14M— | $7M+800% | ||
| —— | $109M-94.1% | $542M-63.9% | $975M-16.1% | $1.41B+71.2% | ||
| $186M-6.5% | $162M-6.9% | $171M+8,650% | $154M+65.6% | $199M+1,147% | ||
| —— | —— | —— | —— | —— | ||
| —— | $385M-78.4% | $734.5M-49.5% | $1.08B-3.8% | $1.43B+79.6% | ||
| $1.65B-2.9% | $1.66B-32.5% | $1.73B-70.0% | $1.71B-81.5% | $1.7B-86.5% | ||
| $470M-36.8% | $720M+6.7% | $460M-38.2% | $434M-46.7% | $744M+40.9% | ||
| —— | —— | —— | —— | —— | ||
| $12.52B+4.9% | $12.38B+4.7% | $12.23B+4.5% | $12.09B+4.3% | $11.94B+2.1% | ||
| $4.14B+279% | $3.42B+308% | $1.96B+117% | $1.11B-2.2% | $1.09B-15.9% | ||
| -$662M— | -$34M— | —— | —— | —— | ||
| $18.24B— | $14.59B— | $13.97B— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $13.43B+25.6% | $12.33B+30.3% | $11.63B+20.2% | $10.61B-20.1% | $10.69B-42.1% | ||
| —— | $1.98B-0.7% | $1.98B+1.5% | $1.98B+3.7% | $1.99B+6.0% | ||
| —— | $2.59B+67.1% | $2.33B+53.2% | $2.07B+38.7% | $1.81B+23.7% | ||
| $17.78B-12.7% | $19.7B-0.7% | $19.6B-5.5% | $18.55B-8.6% | $20.37B+8.9% | ||
| $17.78B-12.7% | $19.7B-0.7% | $19.6B-5.5% | $18.55B-8.6% | $20.37B+8.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Johnson & Johnson generate?
- Johnson & Johnson (JNJ) generated $22.9B in operating cash flow over the trailing twelve months.
- What is Johnson & Johnson's free cash flow?
- After $5.1B of capital expenditures, Johnson & Johnson's free cash flow was $17.8B over the trailing twelve months, down 12.7% year over year.
- Where does Johnson & Johnson's cash flow data come from?
- Every line is extracted from Johnson & Johnson's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
